Antengene Co Ltd Sustainability Reports
Antengene Corporation Limited is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative oncology and autoimmune therapeutics. The company specializes in novel combinations and target mechanisms, primarily serving markets in the Asia-Pacific region and globally.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 655600N0NSGOMS4CVH68
FIGI: BBG00Y4731N4
6 reports from 2020 to 2024
